Spotlight Series on Hepatitis C

New FDA Hepatitis List Serve

March 12, 2009

The Food and Drug Administration is launching a new hepatitis list serve. This new e-mail list will provide updates on safety and regulatory issues related to hepatitis B and C products as they become available (rather than on a regularly scheduled basis).

The e-mail list is intended to give patients, industry, academia, government agencies, and other interested parties, one source for FDA hepatitis B and C related information on a variety of topics, including:

  • product approvals
  • significant labeling changes
  • safety warnings
  • notices of upcoming public meetings
  • proposed regulatory guidances and opportunity to comment

You can subscribe to the new hepatitis e-mail list by simply clicking the link below:

or pasting it into your browser.

You will get an e-mail acknowledgment shortly after signing up.

Richard Klein
Office of Special Health Issues
Food and Drug Administration

Kimberly Struble
Division of Antiviral Drug Products
Food and Drug Administration

This article was provided by U.S. Food and Drug Administration. Visit the FDA's website to find out more about their activities and publications.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.